| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |